CClinicalTrials.gg
Not yet recruitingNCT06742658OUTSIDEUpdated Dec 19, 2024

Rapid Move Following Outpatient Surgery: Safety and Patient Characteristics

An observational study in Postoperative Recovery, sponsored by Algemeen Ziekenhuis Maria Middelares. Not yet recruiting at 1 site in Belgium. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2024-12-19.

Sponsored by Algemeen Ziekenhuis Maria Middelares · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,500
Ages
15 Years and older
Sex
All
01

Study summary

A descriptive, retrospective cohort study will be conducted to gain insight in the safety of the Rapid Move. The trial will include a group of Rapid Move patients, who were transferred to the Rapid Move after their outpatient surgery and subsequently discharged home. The Rapid Move is a short-stay PACU where patients recover from anaesthesia, are continuously monitored, and prepared for discharge within an hour after surgery.

Read the detailed description

The Rapid Move, a short-stay PACU unit, was implemented at General Hospital Maria Middelares in Ghent, Belgium. The Rapid Move is designed to alleviate the bottleneck in the day surgery unit. Overcrowding in the PACU, caused by limited space in the day surgery unit, resulted in delays in patient discharge despite patients meeting discharge criteria. The Rapid Move is designed for brief, intensive follow-up care, similar to the PACU, with continuous monitoring and a nurse-to-patient ratio of 2:9. An analysis of the occupancy rate of the PACU and the Rapid Move indicates that, despite overcrowding in the PACU, the Rapid Move is still underutilised. Despite the extensive research on PACU bypassing, to our knowledge, no research has been conducted on the safety of the Rapid Move, a short-stay PACU where patients recover from anaesthesia, are continuously monitored and prepared for discharge within an hour after surgery. The aim of this retrospective cohort study is to gain insight in the safety of the Rapid Move as an alternative postoperative pathway for outpatients.

Furthermore, the underutilisation of the Rapid Move, despite the overcrowding of the PACU, has highlighted the need to develop a patient profile of eligible patients for the Rapid Move, with the intention to expand the selection criteria for the Rapid Move and optimise its capacity.

02

Conditions studied

  • Postoperative Recovery

Keywords

  • Postoperative recovery
  • PACU
  • Rapid Move
03

In context

Lead sponsor

Algemeen Ziekenhuis Maria Middelares is the lead sponsor of 36 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study will include an intervention group with all consecutive patients, aged 15 years or older, who went to the Rapid Move after their outpatient procedure between 1 December 2023 and 1 December 2024 in general hospital Maria Middelares, Ghent, Belgium (Rapid Move patients).

Inclusion criteria

  • Patients aged 15 years or older;
  • Patients who went to the Rapid Move after their outpatient procedure. Eligible procedures are: gastroscopy, coloscopy, vasectomy, scrotal surgery, circumcision or other minor penile surgery, intravesical Botox, insertion or removal of eardrum tubes in adults, sinus irrigation in adults, sleep endoscopy, bronchoscopy, removal of osteosynthetic material in the lower leg and foot, and tooth extraction (including wisdom teeth) and upper-forearm orthopedic surgery (excluding prosthetic surgery).

Exclusion criteria

Exclusion Criteria:

  • Inpatients defined as a patient who is formally admitted (or "hospitalized") to an institution for treatment and/or care and stays for a minimum of one night in the hospital or other institution providing inpatient care;
  • Patients undergoing emergency procedures.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,500 participants (estimated)
Patient registry
No

Groups and cohorts

  • All patients undergoing an outpatient procedure eligible for the Rapid Move.

    Patients who went to the Rapid Move after their outpatient procedure. Eligible procedures are: gastroscopy, coloscopy, vasectomy, scrotal surgery, circumcision or other minor penile surgery, intravesical Botox, insertion or removal of eardrum tubes in adults, sinus irrigation in adults, sleep endoscopy, bronchoscopy, removal of osteosynthetic material in the lower leg and foot, and tooth extraction (including wisdom teeth) and upper-forearm orthopaedic surgery (excluding prosthetic surgery).

    Other: Rapid Move

Interventions

  • OtherRapid Move

    A short-stay PACU where patients recover from anaesthesia, are continuously monitored, and prepared for discharge within an hour after surgery.

06

What researchers measure

Primary outcomes

  1. 30-day readmission

    The 30-day readmission rate is defined as the number of patients with an unplanned emergency hospital readmission, including emergency department (ED) visits with or without hospital readmission, occurring between the time the patient is discharged from the hospital after their outpatient surgery (index hospital admission) and 30 days after the surgery. An admission to a non-acute care facility is not considered a readmission. A readmission must be clinically related to the index hospital admission. The term 'clinically related' is defined as meaning that the underlying reason for readmission is plausibly related to the care rendered during or immediately following a prior hospital admission. A clinically related readmission may have resulted from the process of care and treatment during the prior admission or from a lack of post-admission follow-up, rather than from events that occurred after the prior admission within a specified readmission time interval that are unrelated to the p

    Time frame: Up to 30 days after hospital discharge.

Secondary outcomes

  1. Complications

    Readmission reason, classified using the International Classification for Diseases (ICD)-11.

    Time frame: Up to 30 days after hospital discharge.

  2. Length of Stay

    The time between the arrival at the Rapid Move unit and the time of hospital discharge.

    Time frame: Minutes, up to 4 hours.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06742658
Lead sponsor
Algemeen Ziekenhuis Maria Middelares
Collaborators
University Ghent
Responsible party
Ella Hemie (studiecoordinator, PhD student, Algemeen Ziekenhuis Maria Middelares) — Principal investigator
First posted
Dec 19, 2024
Start date
Dec 2025 (estimated)
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Dec 19, 2024

Study contacts

Ella Hermie, MSc
Contact
ella.hermie@mijnziekenhuis.be
0032 9 246 17 03
Ella Hermie, MSc
principal investigator · Algemeen Ziekenhuis Maria Middelares

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion